Study to identify best rehabilitation therapies for patients with traumatic brai...( CHICAGO Rush University Medical Cen...),Health
Navigation Links
Study to identify best rehabilitation therapies for patients with traumatic brain injuries
Date:12/15/2008
CHICAGO Rush University Medical Center and 10 other healthcare facilities in the U.S. and Canada have been awarded a $4.3 million grant from the National Institutes of Health to identify which rehabilitation therapies, or combination of therapies, can best help victims of traumatic brain injuries. Rush is the only center in Illinois participating in the study.
"Our aim in this study is to isolate individual components of the range of therapies we use to treat our patients and determine how, and to what degree, each is associated with improved function," said Dr. James Young, chairman of the department of physical medicine and rehabilitation at Rush and an internationally recognized expert in the treatment of brain injuries.
The five-year study will collect the records of more than 2,300 patients who have suffered moderate to severe traumatic brain injuries, including detailed demographic, diagnostic and clinical profiles of each patient. Daily logs will be kept of the individually tailored treatment programs the patients undergo in physical therapy, occupational therapy, speech/language therapy, physiatry (physical medicine), psychology/psychiatry, and social support. Outcomes will be catalogued and correlated with both the patients' characteristics and therapeutic interventions.
The researchers will then analyze the data to determine which therapies were the most successful in improving outcomes for patients with different types and severities of traumatic brain injuries.
Patients will also be followed for a full year after being discharged to assess their quality of life, including whether they were able to live independently, drive a vehicle, and participate in daily activities.
The analysis will involve an unusual research methodology called practice-based evidence for clinical practice improvement, which relies on data from routine clinical practice to determine what works for whom, when, and at what cost. Th
'/>"/>
| Contact: Sharon Butler sharon_butler@rush.edu 312-942-7816 Rush University Medical Center Source:Eurekalert |
Related medicine news :
1. Double Blind Study Proves The Pink Patch Works for Weight Loss
2. First Patient from CyberKnife Center of Palm Beach Enrolled in Worldwide Landmark Study of Operable Lung Cancer Patients
3. Planned safety analysis of a breast cancer prevention study reveals encouraging news for Exemestane
4. Genomic Health Announces Study Establishing the Utility of Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated with Aromatase Inhibitors
5. Wyeth Announces Positive Data from Phase 2 Study of Neratinib in Advanced HER-2-Positive Breast Cancer
6. Partnership for a Drug-Free America(R) Responds to 2008 Monitoring the Future Study Results
7. UB driver simulation study targets high-risk teenage drivers
8. Employer Vantage From HealthLeaders-InterStudy Provides a Snapshot of Both Self- and Fully-Insured Health Benefits to Help Pharmaceutical and Diagnostic Manufacturers Identify Business Opportunities
9. Study shows major pain research funding decline at NIH
10. Womens magazines downplay emotional health risks of cosmetic surgery: UBC study
11. Study Asks: Are Physicians Overusing an Invasive Cardiac Treatment?
Post Your Comments:
(Date:11/27/2009)...nt Health™ announced today that Spectrum Hea...maCad Enterprise orthopedic templating solution an... (PRWEB) November 27, 2009 -- Vo...ealth (Grand Rapids, Michigan) has licensed its Tr...and its TraumaCad Extend workflow solution, to all...
(Date:11/27/2009)...e new interactive anatomy education apps from Moda...health sciences learning opportunities for iPhone ...NC (Vocus) November 27, 2009 -- Modality, Inc. a...sion of Wolters Kluwer Health, today announced the...on the App Store. Clemente’s Anatomy, Rohen&...
(Date:11/26/2009)...mber of Americans living with diabetes will nearly...4.1 million in 2034. Over the same period, spendin... billion to $336 billion, even with no increase in...he University of Chicago report in the December is...th diabetes covered by Medicare will rise from 8.2...
(Date:11/26/2009)...on an emotional rollercoaster, study finds , ...it the fear factor meets the jubilant sports fan. ...ially those who root for the winning team -- enjoy...sted match and victory was in doubt, producing fee... this Thanksgiving weekend as you,re glued to the ...
(Date:11/26/2009)...arch Triangle Dental (RTDental), a leading dental ...nounced the expansion of its services to include L... Macmillan. , Durham, ...to announce that Dr. Doug Macmillan, an experience...ional advanced training seminar. RTDental’s...
Breaking Medicine News(10 mins):Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2[0] Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend[0] Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store[0] Diabetes cases to double and costs to triple by 2034[0] Watching the Nail-Biting Big Game Hurts So Good[0] Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental
...ts first patient in a 60-patient Phase 2 clinical ...e peroxidase mimetic, in diabetic patients with a...risk for cardiovascular complications.
This ... cardiovascular events.
It builds on posit...
...) and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) to...tion (sNDA) for Nexavar(R) (sorafenib) tablets ha...tration (FDA) for the treatment of patients with h... advanced kidney cancer. The companies also confir...
...VI) today announced the results of work on genome ... one type of bacteria into another type dictated b...lished online in the journal Science, by JCVI's Ca...oplasma mycoides Large Colony (LC), by replacing o...
...ar effect to antidepressants on depression. Exerci...series of scientific reports, she has searched for... why exercise can be a form of therapy for depress... that both exercise and antidepressants increase t...
...es to smoke tobacco are waging an 11th-hour bid fo...rce in England on Sunday.
Without the shi...riously called, dozens of restaurants will lose th... are blocked with an 11-years lease signed in 2003...
...Friday it had withdrawn an application for regulat... the United States.
A panel of experts fr...arlier this month that the dieting treatment, refe... rimonabant file to the FDA at a future date," the...
Other Medicine News:Health News:Alteon Initiates Phase 2 Trial of ALT-2074 in Diabetes and Haptoglobin 2-2 2Health News:Bayer and Onyx Submit Supplemental New Drug Application for Nexavar to Treat Liver Cancer 2Health News:First Bacterial Genome Transplantation Changing One Species to Another 2Health News:Shisha Owners Mobilise Against July 1 Smoking Ban in England 2Health News:Shisha Owners Mobilise Against July 1 Smoking Ban in England 3Alteon Initiates Phase 2 Trial of ALT-2074 in Diabetes and Haptoglobin 2-2Bayer and Onyx Submit Supplemental New Drug Application for Nexavar to Treat Liver CancerFirst Bacterial Genome Transplantation Changing One Species to AnotherNew Braincells can Be Induced by ExerciseShisha Owners Mobilise Against July 1 Smoking Ban in EnglandSanofi Withdraws Anti-obesity Drug in US
(Date:11/27/2009)... , Another option to prevent illnesses ca...ILVER SPRING, Md., Nov. 27 /PRNewswire-USNewswire/...proved Agriflu for people ages 18 years and older ...pes A and B. ,, (Logo: http://www.newscom.co...anufactured by Novartis Vaccines and Diagnostics i...
(Date:11/25/2009)... , CANOGA PARK, Calif., Nov. 25 /PRNewswire/ ...t place rankings in the American Academy of Family...M) 2009 EHR User Satisfaction Survey for improving...management, all critical for new ARRA Stimulus leg...cating their EMR had a positive effect in determin...
(Date:11/25/2009)... , PHILADELPHIA, Nov. 25 /PRNewswire-First...t Dr. Michael J. McKelvey, the Company,s President...ve Vice President and CFO, are scheduled to presen...ference at 1:30 PM EST on December 1, 2009 in New ...access the presentation by visiting the Company,s ...
Breaking Medicine Technology:FDA Approves Agriflu Seasonal Influenza Vaccine 2Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2GetWellNetwork Introduces Discharge Planning Tools in Latest Version of PatientLife System 51786 1GetWellNetwork Introduces Discharge Planning Tools in Latest Version of PatientLife System 51786 2GetWellNetwork Introduces Discharge Planning Tools in Latest Version of PatientLife System 51786 3GetWellNetwork Introduces Discharge Planning Tools in Latest Version of PatientLife System 51786 4Demand for Short Term Medical Help Leads to Growth for Travel Nursing Staffing Agency 3B Prompts Move to New Location and Addition of New Online Tools 51782 1Demand for Short Term Medical Help Leads to Growth for Travel Nursing Staffing Agency 3B Prompts Move to New Location and Addition of New Online Tools 51782 2CNCB Post Graduate Studies in Clinical Nutrition 28PGSCN 29 Program is Now Available Online 51778 1CNCB Post Graduate Studies in Clinical Nutrition 28PGSCN 29 Program is Now Available Online 51778 2... of Antidote Component, ORLANDO, Fla., Nov. 4 Re...mized, double-blind, placebo-controlled Phase Ic,s... REG1 is a two-component,system comprised of an ap...antidote, RB007, which binds to and neutralizes RB...reverse the anticoagulant effect of RB006 either,c...
...PARK, N.C., Nov. 2 /PRNewswire/,-- Fabre-Kramer Ph...: GSK ),announced today that the U.S. Food and Dr...e letter for the new drug application for gepirone... treatment of adults with major,depressive disorde...h III clinical data,involving gepirone ER. In June...
Other Medicine Technology:Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions 2Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions 3Fabre Kramer Pharmaceuticals Receives Decision From FDA on Gepirone ER for Major Depressive Disorder 2| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |